-
Something wrong with this record ?
Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults
BI. Perry, J. Stochl, R. Upthegrove, S. Zammit, N. Wareham, C. Langenberg, E. Winpenny, D. Dunger, PB. Jones, GM. Khandaker
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
MC_UU_12015/1
Medical Research Council - United Kingdom
MR/L010305/1
Medical Research Council - United Kingdom
201486/Z/16/Z
Wellcome Trust - United Kingdom
MC_PC_15018
Medical Research Council - United Kingdom
G9815508
Medical Research Council - United Kingdom
102215/2/13/2
Wellcome Trust - United Kingdom
MR/T010576/1
Medical Research Council - United Kingdom
MC_PC_17213
Medical Research Council - United Kingdom
217065/Z/19/Z
Wellcome Trust - United Kingdom
MR/S037675/1
Medical Research Council - United Kingdom
MC_UU_00006/1
Medical Research Council - United Kingdom
08426812/Z/07/Z
Wellcome Trust - United Kingdom
MC_PC_19009
Medical Research Council - United Kingdom
MR/M006727/1
Medical Research Council - United Kingdom
DRF-2018-11-ST2-018
Department of Health - United Kingdom
- MeSH
- Depressive Disorder epidemiology MeSH
- Child MeSH
- Adult MeSH
- Risk Assessment MeSH
- Body Mass Index * MeSH
- Insulin blood MeSH
- Cardiometabolic Risk Factors * MeSH
- Infant MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Adolescent MeSH
- Young Adult MeSH
- Child, Preschool MeSH
- Psychotic Disorders epidemiology MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- United Kingdom MeSH
Importance: Cardiometabolic disorders often occur concomitantly with psychosis and depression, contribute to high mortality rates, and are detectable from the onset of the psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic traits from childhood are associated with risks for adult psychosis and depression. Objective: To examine whether specific developmental trajectories of fasting insulin (FI) levels and body mass index (BMI) from early childhood were longitudinally associated with psychosis and depression in young adults. Design, Setting, and Participants: A cohort study from the Avon Longitudinal Study of Parents and Children, a prospective study including a population-representative British cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years. Body mass index and FI level data were used for growth mixture modeling to delineate developmental trajectories, and associations with psychosis and depression were assessed. The study was conducted between July 15, 2019, and March 24, 2020. Exposures: Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal social class, childhood emotional and behavioral problems, and cumulative scores of sleep problems, average calorie intake, physical activity, smoking, and alcohol and substance use in childhood and adolescence were examined as potential confounders. Main Outcomes and Measures: Psychosis risk (definite psychotic experiences, psychotic disorder, at-risk mental state status, and negative symptom score) depression risk (measured using the computerized Clinical Interview Schedule-Revised) were assessed at 24 years. Results: From data available on 5790 participants (3132 [54.1%] female) for FI levels and data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated by mid-childhood. The persistently high FI level trajectory was associated with a psychosis at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic disorder (aOR, 3.22; 95% CI, 1.29-8.02) but not depression (aOR, 1.38; 95% CI, 0.75-2.54). A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI, 2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79). Conclusions and Relevance: The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset major increase in BMI could be a risk factor or risk indicator for adult depression. These markers may represent targets for prevention and treatment of cardiometabolic disorders in individuals with psychosis and depression.
Cambridgeshire and Peterborough NHS Foundation Trust Cambridge United Kingdom
Department of Kinanthropology Charles University Prague Czechia
Institute for Mental Health University of Birmingham Birmingham United Kingdom
MRC Centre for Neuropsychiatric Genetics and Genomics Cardiff University Cardiff United Kingdom
MRC Epidemiology Unit University of Cambridge School of Clinical Medicine Cambridge United Kingdom
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012495
- 003
- CZ-PrNML
- 005
- 20220506131048.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1001/jamapsychiatry.2020.4180 $2 doi
- 035 __
- $a (PubMed)33439216
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Perry, Benjamin I $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
- 245 10
- $a Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults / $c BI. Perry, J. Stochl, R. Upthegrove, S. Zammit, N. Wareham, C. Langenberg, E. Winpenny, D. Dunger, PB. Jones, GM. Khandaker
- 520 9_
- $a Importance: Cardiometabolic disorders often occur concomitantly with psychosis and depression, contribute to high mortality rates, and are detectable from the onset of the psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic traits from childhood are associated with risks for adult psychosis and depression. Objective: To examine whether specific developmental trajectories of fasting insulin (FI) levels and body mass index (BMI) from early childhood were longitudinally associated with psychosis and depression in young adults. Design, Setting, and Participants: A cohort study from the Avon Longitudinal Study of Parents and Children, a prospective study including a population-representative British cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years. Body mass index and FI level data were used for growth mixture modeling to delineate developmental trajectories, and associations with psychosis and depression were assessed. The study was conducted between July 15, 2019, and March 24, 2020. Exposures: Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal social class, childhood emotional and behavioral problems, and cumulative scores of sleep problems, average calorie intake, physical activity, smoking, and alcohol and substance use in childhood and adolescence were examined as potential confounders. Main Outcomes and Measures: Psychosis risk (definite psychotic experiences, psychotic disorder, at-risk mental state status, and negative symptom score) depression risk (measured using the computerized Clinical Interview Schedule-Revised) were assessed at 24 years. Results: From data available on 5790 participants (3132 [54.1%] female) for FI levels and data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated by mid-childhood. The persistently high FI level trajectory was associated with a psychosis at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic disorder (aOR, 3.22; 95% CI, 1.29-8.02) but not depression (aOR, 1.38; 95% CI, 0.75-2.54). A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI, 2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79). Conclusions and Relevance: The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset major increase in BMI could be a risk factor or risk indicator for adult depression. These markers may represent targets for prevention and treatment of cardiometabolic disorders in individuals with psychosis and depression.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a index tělesné hmotnosti $7 D015992
- 650 12
- $a kardiometabolické riziko $7 D000083202
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a depresivní poruchy $x epidemiologie $7 D003866
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a inzulin $x krev $7 D007328
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a psychotické poruchy $x epidemiologie $7 D011618
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Spojené království $x epidemiologie $7 D006113
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Stochl, Jan $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Department of Kinanthropology, Charles University, Prague, Czechia
- 700 1_
- $a Upthegrove, Rachel $u Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom
- 700 1_
- $a Zammit, Stan $u Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom $u MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom
- 700 1_
- $a Wareham, Nick $u MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
- 700 1_
- $a Langenberg, Claudia $u MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
- 700 1_
- $a Winpenny, Eleanor $u MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
- 700 1_
- $a Dunger, David $u Department of Paediatrics, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
- 700 1_
- $a Jones, Peter B $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
- 700 1_
- $a Khandaker, Golam M $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom $u Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom $u Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom $u MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
- 773 0_
- $w MED00180928 $t JAMA psychiatry $x 2168-6238 $g Roč. 78, č. 4 (2021), s. 416-425
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33439216 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131040 $b ABA008
- 999 __
- $a ok $b bmc $g 1789903 $s 1163696
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 78 $c 4 $d 416-425 $e 20210401 $i 2168-6238 $m JAMA psychiatry $n JAMA Psychiatry $x MED00180928
- GRA __
- $a MC_UU_12015/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MR/L010305/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a 201486/Z/16/Z $p Wellcome Trust $2 United Kingdom
- GRA __
- $a MC_PC_15018 $p Medical Research Council $2 United Kingdom
- GRA __
- $a G9815508 $p Medical Research Council $2 United Kingdom
- GRA __
- $a 102215/2/13/2 $p Wellcome Trust $2 United Kingdom
- GRA __
- $a MR/T010576/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_PC_17213 $p Medical Research Council $2 United Kingdom
- GRA __
- $a 217065/Z/19/Z $p Wellcome Trust $2 United Kingdom
- GRA __
- $a MR/S037675/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_UU_00006/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a 08426812/Z/07/Z $p Wellcome Trust $2 United Kingdom
- GRA __
- $a MC_PC_19009 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MR/M006727/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a DRF-2018-11-ST2-018 $p Department of Health $2 United Kingdom
- LZP __
- $a Pubmed-20220425